Skip to main content

Cocaine Addiction

1
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
1 program
1
N-AcetylcysteinPhase 41 trial
Active Trials
NCT02626494Completed71Est. Mar 2017
Teva
TevaIsrael - Petach Tikva
1 program
TV-1380 150 mgPHASE_21 trial
Active Trials
NCT01887366Completed208Est. Oct 2014
Catalyst Pharmaceuticals
Catalyst PharmaceuticalsCORAL GABLES, FL
1 program
VigabatrinPHASE_2_31 trial
Active Trials
NCT01281202Completed207Est. Dec 2012
Mission Therapeutics
Mission TherapeuticsUK - Cambridge
1 program
Modafinil and PETPHASE_31 trial
Active Trials
NCT00701532Completed29Est. Jan 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencesN-Acetylcystein
Mission TherapeuticsModafinil and PET
Catalyst PharmaceuticalsVigabatrin
TevaTV-1380 150 mg

Clinical Trials (4)

Total enrollment: 515 patients across 4 trials

NCT02626494Human BioSciencesN-Acetylcystein

Neurobiological Adaptations and Pharmacological Interventions in Cocaine Addiction

Start: Mar 2015Est. completion: Mar 201771 patients
Phase 4Completed
NCT00701532Mission TherapeuticsModafinil and PET

Brain Imaging Study of the Effects of Modafinil in Cocaine Addiction

Start: Apr 2009Est. completion: Jan 201329 patients
Phase 3Completed
NCT01281202Catalyst PharmaceuticalsVigabatrin

Vigabatrin for the Treatment of Cocaine Dependency

Start: Jan 2011Est. completion: Dec 2012207 patients
Phase 2/3Completed
NCT01887366TevaTV-1380 150 mg

Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects

Start: Jun 2013Est. completion: Oct 2014208 patients
Phase 2Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.